Chemistry - A European JournalImmunologyPeer-reviewed journal article
Identification of small molecule enhancers of NK cell tumoricidal activity via a tumor microenvironment-mimicking co-culture assay
Aylin BiniciiD, Elisabeth Hennes, Sandra KoskaiD, Jens Alexander NiemanniD, Alisa Reich, Christiane Pfaff, Sonja SieversiD, Astrid Stefanie KahntiD, Dominique ThomasiD, Slava ZiegleriD, Carsten WatzliD, Herbert WaldmanniD
Abstract
The tumor microenvironment (TME) is a pro-cancerous niche harboring immunosuppressive factors that are secreted by cancer cells and the surrounding cancer-supportive tissue, such as kynurenine, prostaglandin E2 and transforming growth factor {beta} (TGF{beta}). These factors dampen the activity of cytotoxic lymphocytes like natural killer (NK) cells, allowing evasion of immune cell-mediated killing. To identify small molecules that counteract the immunosuppressive effect of the TME and restore NK cell-mediated cytotoxicity, we developed a phenotypic co-culture assay of cancer cells and primary lymphocytes suitable for medium-throughput screening. We discovered small molecules that restore NK cell-mediated cytotoxicity through diverse mechanisms. The potent TGF{beta} type I receptor (TGF{beta}R-1) inhibitor, RepSox, stood out as superior to other TGF{beta}R-1 inhibitors due to its ability to abolish the effects of both inhibitory factors used in our setup. This mode of action goes beyond TGF{beta}R-1 inhibition and is related to the simultaneous abrogation of cyclooxygenase 1 (COX1) activity.
- Citations
- 1
- FWCI
- 0.33
- Field percentile
- 47th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Ammonia inhibits antitumor activity of NK cells by decreasing mature perforin
M. Winiarska, J. Domagala, … C. Watzl·bioRxiv·Nov 20, 2023
- Glucocorticoid receptor activation reprograms NK cells to drive AREG-mediated immunosuppression in skin cancer
- Therapeutic blockade of Activin-A improves NK cell function and anti-tumor immunity
Jai Rautela, Laura F. Dagley, … Fernando Souza-Fonseca-Guimaraes·bioRxiv·Oct 29, 2018
- Cancer-associated fibroblasts serve as decoys to suppress NK cell anti-cancer cytotoxicity
A. Ben-Shmuel, Y. Gruper, … R. Scherz-Shouval·bioRxiv·Nov 23, 2023
- A small molecule drug screening identifies colistin sulfate as an enhancer of Natural Killer cell cytotoxicity.
S. Cortes-Kaplan, M. Hasim, … M. Ardolino·bioRxiv·Aug 20, 2021
- Tumor expressed CD95 causes suppression of anti-tumor activity of NK cells in a model of triple negative breast cancer
A. S. Qadir, J. P. Guegan, … M. E. Peter·bioRxiv·Feb 12, 2021